New combo pill tackles two heart risks at once
NCT ID NCT06165250
First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 34 times
Summary
This study tested whether taking two experimental drugs together (BR1018B and BR1018C) can safely lower both blood pressure and LDL cholesterol in people with essential hypertension and primary hypercholesterolemia. A total of 156 adults participated. The main goals were to see how much blood pressure and cholesterol dropped after 8 weeks compared to a control group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Keimyung University Dongsan Hospital
Daegu, South Korea
-
Seoul National University Boramae Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.